ARTG 375853Avance Solo NPWT System - Negative-pressure wound therapy system, battery-powered, single-use
ARTG ID: 375853 · Molnlycke Health Care Pty Ltd · Molnlycke Health Care AB · Class IIa · Started October 06, 2021
Good Name: Molnlycke Health Care Pty Ltd - Avance Solo NPWT System - Negative-pressure wound therapy system, battery-powered, single-use
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 375853
- Start Date
- October 06, 2021
- Effective Date
- October 06, 2021
- Country
- Sweden
- Address
- Gamlestadsvagen 3C Box 13080, Goteburg, SE-402 52
Avance® Solo Sets are part of Avance Solo Negative Pressure Wound Therapy System. It consists of Pump and Canister. Avance® Solo NPWT System is indicated for removal of low to moderate amounts of exudates from chronic, acute, traumatic, subacute and dehisced wounds, ulcers (such as diabetic, venous or pressure), surgically closed incisions, flaps, and grafts.
Access comprehensive regulatory information for Avance Solo NPWT System - Negative-pressure wound therapy system, battery-powered, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 375853 and sponsored by Molnlycke Health Care Pty Ltd, manufactured by Molnlycke Health Care AB in Sweden. The device registration started on October 06, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.